ROR1 and renal cell carcinoma: Specifically, the assessment of antigen-receptor dependent killing of RCC spheroids expressing ROR1, a tumor antigen under clinical trial investigation, unveiled limited T-cell infiltration into the high-density collagen matrix compared to low-density collagen.